1. Home
  2. LCID vs IRON Comparison

LCID vs IRON Comparison

Compare LCID & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lucid Group Inc.

LCID

Lucid Group Inc.

HOLD

Current Price

$11.20

Market Cap

3.7B

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$78.47

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCID
IRON
Founded
2007
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LCID
IRON
Price
$11.20
$78.47
Analyst Decision
Hold
Strong Buy
Analyst Count
8
12
Target Price
$24.00
$110.08
AVG Volume (30 Days)
8.6M
537.0K
Earning Date
02-24-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,065,533,000.00
N/A
Revenue This Year
$64.76
N/A
Revenue Next Year
$84.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
45.86
N/A
52 Week Low
$9.50
$30.82
52 Week High
$35.90
$99.50

Technical Indicators

Market Signals
Indicator
LCID
IRON
Relative Strength Index (RSI) 49.07 48.41
Support Level $10.55 $74.42
Resistance Level $11.69 $82.26
Average True Range (ATR) 0.64 3.70
MACD 0.14 0.83
Stochastic Oscillator 65.28 72.31

Price Performance

Historical Comparison
LCID
IRON

About LCID Lucid Group Inc.

Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It offers its own geographically distributed retail and service locations and through direct-to-consumer online and retail sales. It also boasts a product roadmap of future vehicle programs and technologies. It focuses on in-house hardware and software innovation, vertical integration, and a clean-sheet approach to engineering and design led to the development of the Lucid Air. The Lucid Air is a luxury sedan that redefines both the luxury car segment and the EV space. Its geographic segments include North America, the Middle East, and Other International.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: